Minimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa
Juraiporn Somboonwong1★, Mariem Yusuksawad1, Somboon Keelawat2, Sirima Thongruay3, Ubon Poumsuk2★ Corresponding author
- 1Departments of Physiology, University, Thailand.
- 2Pathology, Faculty of Medicine, Chulalongkorn University, Thailand.
- 3Research and Development Center for Livestock Production Technology, Faculty of Veterinary Science, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
CORRESPONDENCE
Juraiporn Somboonwong
Departments of Physiology, University, Thailand.
Received: 27-09-2015; Revised: 07-12-2015.
Volume 12, Issue 46s · pp. S175–S180 · PUBLISHED 11 May 2016 · DOI: 10.4103/0973-1296.182169
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Microangiopathy is a chronic diabetic complication resulting from metabolic derangements, oxidative stress, and increased pro‑inflammatory cytokine production. Nigella sativa Linn. is used as an herbal medicine that exerts hypoglycemic, antilipidemic, anti‑inflammatory, and antioxidant effects. Objective: To examine the effects of N. sativa extract on cutaneous microvascular changes in diabetic rats. Materials and Methods: Sprague‑Dawley rats were randomly assigned into the following four groups: Untreated and N. sativa‑treated normal controls and untreated and N. sativa‑treated rats with streptozotocin‑induced diabetes. A cold‑pressed N. sativa extract was then orally administered (1000 mg/kg/day). After 8 weeks of treatment, the glucose, glycosylated hemoglobin (HbA1c), tumor necrosis factor‑alpha (TNF‑α), insulin levels, and lipid profile were determined in cardiac blood. Dermal capillary wall thickness was measured in tail skin sections stained with periodic acid‑Schiff. Endothelial apoptosis was morphologically evaluated by hematoxylin and eosin staining. Results: Diabetes significantly reduced the circulating insulin and low‑density lipoprotein levels and caused elevations in the glucose, HbA1c, and triglyceride levels, accompanied by a slight increase in total cholesterol levels and no change in the high‑density lipoprotein and TNF‑α levels. Capillary basement membrane thickening and a decreased capillary luminal diameter despite no evidence of endothelial cell apoptosis were also observed. N. sativa treatment of diabetic rats reduced the mean HbA1c concentration by 1.4%, enlarged the capillary lumens, and tended to attenuate dermal capillary basement membrane thickening without affecting the lipid profile or TNF‑α level. Conclusion: Our results indicate that N. sativa may be used to minimize the risk of diabetic microangiopathy, potentially due in part to its glycemic control activity.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Somboonwong, J., Yusuksawad, M., Keelawat, S., Thongruay, S., & Poumsuk, U. (2016). Minimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa. Pharmacognosy Magazine, 12(46s), S175–S180. https://doi.org/10.4103/0973-1296.182169